FinanceCity
HealthcareNSE · BSE

Metropolis Healthcare Limited

METROPOLIS · ISIN INE112L01020

Share price

₹537 +2.14%

Market capitalisation

₹11137 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹11137 Cr

Current price

₹537

+2.14% today

52W high

₹600

52W low

₹412

Stock P/E

58.39

P/B ratio

7.35

02 · Per share & returns

EPS (TTM)

₹9.20

Book value

₹73.13

ROE

13.37%

ROA

8.34%

Dividend yield

0.38%

Beta

0.21

03 · Financials (TTM)

By the numbers

Revenue

₹1646 Cr

+23.00% YoY

EBITDA

₹401 Cr

Net profit

₹190 Cr

+73.00% YoY

Profit margin

11.54%

Operating margin

16.35%

Total debt

₹232 Cr

Total cash

₹203 Cr

Debt / equity

0.15x

Current ratio

1.40x

Payout ratio

10.88%

04 · Analyst view

Target price

₹609

Upside

+13.30%

Consensus

NONE

Analysts

18

05 · Shareholding pattern

Who owns METROPOLIS?

  • Promoters

    48.87%

    Founders & promoter group

  • Institutions

    44.62%

    FII + DII

  • Public

    6.51%

    Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol
METROPOLIS
Exchange
NSE · BSE
CIN
ISIN
INE112L01020
BSE code
542650
Sector
Healthcare
Industry
Healthcare
Face value
₹2
Listing date
14 Apr 2019
Employees
Headquarters
Mumbai, India

07 · About

What is Metropolis Healthcare Limited?

Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinical trial research, hospital lab management, and home collection services, as well as profiles, blood tests, and soft radiology services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, youth, and corporates. In addition, the company develops and deals in technology driven products and services. The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, a mobile app, a website, and home collection; partnerships with standalone labs, hospital chains, and diagnostic networks; and institutional clients, such as corporates, government bodies, and hospital lab management services. Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India.

08 · Common questions

Frequently asked

What is the CIN of Metropolis Healthcare Limited?+

The Corporate Identity Number for Metropolis Healthcare Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Metropolis Healthcare Limited?+

Promoter holding in METROPOLIS is approximately 48.87%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of Metropolis Healthcare Limited?+

Metropolis Healthcare Limited (METROPOLIS) has a market capitalisation of approximately ₹11137 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other healthcare listings

Full sector →